SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-23-239627
Filing Date
2023-09-21
Accepted
2023-09-21 16:34:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D d546390dsc13d.htm SC 13D 37287
  Complete submission text file 0001193125-23-239627.txt   38894
Mailing Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Dianthus Therapeutics, Inc. /DE/ (Subject) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90538 | Film No.: 231269480
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2001 MARKET STREET, SUITE 2500 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET, SUITE 2500 PHILADELPHIA PA 19103 1-267-760-4066
Viridian, LLC (Filed by) CIK: 0001761506 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D